CA Stock MarketDetailed Quotes

BUX Biomark Diagnostics Inc

Watchlist
  • 0.250
  • 0.0000.00%
15min DelayMarket Closed Apr 17 12:08 ET
22.72MMarket Cap-12.50P/E (TTM)

Biomark Diagnostics Inc Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Dec 31, 2024
(Q2)Sep 30, 2024
(Q1)Jun 30, 2024
(FY)Mar 31, 2024
(Q4)Mar 31, 2024
(Q3)Dec 31, 2023
(Q2)Sep 30, 2023
(Q1)Jun 30, 2023
(FY)Mar 31, 2023
(Q4)Mar 31, 2023
Total revenue
-7.17%38.56K
-8.97%38.35K
-3.61%38.31K
6.34%163.22K
0.15%39.81K
12.62%41.54K
2.85%42.13K
10.71%39.75K
249.38%153.49K
64.82%39.75K
Operating revenue
-7.17%38.56K
-8.97%38.35K
-3.61%38.31K
6.34%163.22K
0.15%39.81K
12.62%41.54K
2.85%42.13K
10.71%39.75K
249.38%153.49K
64.82%39.75K
Cost of revenue
Gross profit
Operating expense
-16.13%359.14K
142.32%569.18K
48.31%642.61K
-21.51%1.48M
-25.03%383.56K
4.87%428.19K
-56.41%234.89K
1.52%433.3K
30.31%1.89M
-28.65%511.64K
Selling and administrative expenses
-1.39%138.91K
24.04%284.68K
114.94%347.24K
-24.71%721.97K
0.29%190.04K
-43.86%140.86K
-38.15%229.52K
9.58%161.55K
69.88%958.96K
-20.53%189.49K
-General and administrative expense
-1.39%138.91K
24.04%284.68K
114.94%347.24K
-24.71%721.97K
0.29%190.04K
-43.86%140.86K
-38.15%229.52K
9.58%161.55K
69.88%958.96K
-20.53%189.49K
Research and development costs
-38.75%113.38K
152.65%238.72K
14.09%182.16K
19.18%650.53K
-20.28%211.29K
209.15%185.11K
31.82%94.49K
6.98%159.65K
9.66%545.84K
-27.62%265.05K
Depreciation amortization depletion
-41.10%58.49K
-35.74%58.17K
-43.66%57.75K
1.81%393.17K
-1.84%100.85K
10.04%99.31K
-6.30%90.52K
6.10%102.5K
115.00%386.2K
-21.15%102.74K
-Depreciation and amortization
-41.10%58.49K
-35.74%58.17K
-43.66%57.75K
1.81%393.17K
-1.84%100.85K
10.04%99.31K
-6.30%90.52K
6.10%102.5K
115.00%386.2K
-21.15%102.74K
Other taxes
--0
69.43%-59.15K
----
---193.49K
--0
--0
---193.49K
----
--0
--0
Other operating expenses
1,555.70%48.36K
237.34%46.76K
478.36%55.47K
-1,599.50%-92.25K
-159.94%-118.62K
-59.74%2.92K
2,557.45%13.86K
-71.39%9.59K
-102.65%-5.43K
-155.97%-45.63K
Operating profit
17.09%-320.58K
-175.38%-530.83K
-53.55%-604.3K
23.98%-1.32M
27.15%-343.76K
-4.10%-386.65K
61.28%-192.76K
-0.68%-393.55K
-23.45%-1.73M
31.91%-471.9K
Net non-operating interest income (expenses)
26.84%-14.68K
10.20%-16.48K
25.01%-18.98K
-1.05%-111.31K
-60.70%-47.58K
9.93%-20.07K
38.86%-18.35K
10.43%-25.31K
-121.71%-110.15K
18.51%-29.61K
Non-operating interest income
--0
-97.40%92
----
4,787.34%3.86K
308.86%323
--0
--3.54K
----
--79
--79
Non-operating interest expense
-26.84%14.68K
-24.30%16.57K
-25.01%18.98K
4.48%115.17K
61.36%47.91K
-9.93%20.07K
-27.07%21.88K
-10.43%25.31K
121.87%110.23K
-18.29%29.69K
Other net income (expenses)
1,295.12%490
638
33
-41
646
Gain on sale of security
1,295.12%490
----
----
--638
--33
---41
--646
----
----
----
Income before tax
17.70%-334.77K
-160.05%-547.31K
-48.80%-623.28K
22.52%-1.43M
21.97%-391.31K
-3.32%-406.76K
60.13%-210.46K
0.07%-418.86K
-26.71%-1.84M
31.29%-501.51K
Income tax
Earnings from equity interest net of tax
Net income
17.70%-334.77K
-160.05%-547.31K
-48.80%-623.28K
22.52%-1.43M
21.97%-391.31K
-3.32%-406.76K
60.13%-210.46K
0.07%-418.86K
-26.71%-1.84M
31.29%-501.51K
Net income continuous operations
17.70%-334.77K
-160.05%-547.31K
-48.80%-623.28K
22.52%-1.43M
21.97%-391.31K
-3.32%-406.76K
60.13%-210.46K
0.07%-418.86K
-26.71%-1.84M
31.29%-501.51K
Noncontrolling interests
Net income attributable to the company
17.70%-334.77K
-160.05%-547.31K
-48.80%-623.28K
22.52%-1.43M
21.97%-391.31K
-3.32%-406.76K
60.13%-210.46K
0.07%-418.86K
-26.71%-1.84M
31.29%-501.51K
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
17.70%-334.77K
-160.05%-547.31K
-48.80%-623.28K
22.52%-1.43M
21.97%-391.31K
-3.32%-406.76K
60.13%-210.46K
0.07%-418.86K
-26.71%-1.84M
31.29%-501.51K
Diluted earnings per share
0.00%-0.02
-295.73%-0.01
0.00%-0.02
0.00%-0.02
0
0.00%-0.02
74.73%-0.0025
0.00%-0.02
0.00%-0.02
0
Basic earnings per share
0.00%-0.02
-295.73%-0.01
0.00%-0.02
0.00%-0.02
0
0.00%-0.02
74.73%-0.0025
0.00%-0.02
0.00%-0.02
0
Dividend per share
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Dec 31, 2024(Q2)Sep 30, 2024(Q1)Jun 30, 2024(FY)Mar 31, 2024(Q4)Mar 31, 2024(Q3)Dec 31, 2023(Q2)Sep 30, 2023(Q1)Jun 30, 2023(FY)Mar 31, 2023(Q4)Mar 31, 2023
Total revenue -7.17%38.56K-8.97%38.35K-3.61%38.31K6.34%163.22K0.15%39.81K12.62%41.54K2.85%42.13K10.71%39.75K249.38%153.49K64.82%39.75K
Operating revenue -7.17%38.56K-8.97%38.35K-3.61%38.31K6.34%163.22K0.15%39.81K12.62%41.54K2.85%42.13K10.71%39.75K249.38%153.49K64.82%39.75K
Cost of revenue
Gross profit
Operating expense -16.13%359.14K142.32%569.18K48.31%642.61K-21.51%1.48M-25.03%383.56K4.87%428.19K-56.41%234.89K1.52%433.3K30.31%1.89M-28.65%511.64K
Selling and administrative expenses -1.39%138.91K24.04%284.68K114.94%347.24K-24.71%721.97K0.29%190.04K-43.86%140.86K-38.15%229.52K9.58%161.55K69.88%958.96K-20.53%189.49K
-General and administrative expense -1.39%138.91K24.04%284.68K114.94%347.24K-24.71%721.97K0.29%190.04K-43.86%140.86K-38.15%229.52K9.58%161.55K69.88%958.96K-20.53%189.49K
Research and development costs -38.75%113.38K152.65%238.72K14.09%182.16K19.18%650.53K-20.28%211.29K209.15%185.11K31.82%94.49K6.98%159.65K9.66%545.84K-27.62%265.05K
Depreciation amortization depletion -41.10%58.49K-35.74%58.17K-43.66%57.75K1.81%393.17K-1.84%100.85K10.04%99.31K-6.30%90.52K6.10%102.5K115.00%386.2K-21.15%102.74K
-Depreciation and amortization -41.10%58.49K-35.74%58.17K-43.66%57.75K1.81%393.17K-1.84%100.85K10.04%99.31K-6.30%90.52K6.10%102.5K115.00%386.2K-21.15%102.74K
Other taxes --069.43%-59.15K-------193.49K--0--0---193.49K------0--0
Other operating expenses 1,555.70%48.36K237.34%46.76K478.36%55.47K-1,599.50%-92.25K-159.94%-118.62K-59.74%2.92K2,557.45%13.86K-71.39%9.59K-102.65%-5.43K-155.97%-45.63K
Operating profit 17.09%-320.58K-175.38%-530.83K-53.55%-604.3K23.98%-1.32M27.15%-343.76K-4.10%-386.65K61.28%-192.76K-0.68%-393.55K-23.45%-1.73M31.91%-471.9K
Net non-operating interest income (expenses) 26.84%-14.68K10.20%-16.48K25.01%-18.98K-1.05%-111.31K-60.70%-47.58K9.93%-20.07K38.86%-18.35K10.43%-25.31K-121.71%-110.15K18.51%-29.61K
Non-operating interest income --0-97.40%92----4,787.34%3.86K308.86%323--0--3.54K------79--79
Non-operating interest expense -26.84%14.68K-24.30%16.57K-25.01%18.98K4.48%115.17K61.36%47.91K-9.93%20.07K-27.07%21.88K-10.43%25.31K121.87%110.23K-18.29%29.69K
Other net income (expenses) 1,295.12%49063833-41646
Gain on sale of security 1,295.12%490----------638--33---41--646------------
Income before tax 17.70%-334.77K-160.05%-547.31K-48.80%-623.28K22.52%-1.43M21.97%-391.31K-3.32%-406.76K60.13%-210.46K0.07%-418.86K-26.71%-1.84M31.29%-501.51K
Income tax
Earnings from equity interest net of tax
Net income 17.70%-334.77K-160.05%-547.31K-48.80%-623.28K22.52%-1.43M21.97%-391.31K-3.32%-406.76K60.13%-210.46K0.07%-418.86K-26.71%-1.84M31.29%-501.51K
Net income continuous operations 17.70%-334.77K-160.05%-547.31K-48.80%-623.28K22.52%-1.43M21.97%-391.31K-3.32%-406.76K60.13%-210.46K0.07%-418.86K-26.71%-1.84M31.29%-501.51K
Noncontrolling interests
Net income attributable to the company 17.70%-334.77K-160.05%-547.31K-48.80%-623.28K22.52%-1.43M21.97%-391.31K-3.32%-406.76K60.13%-210.46K0.07%-418.86K-26.71%-1.84M31.29%-501.51K
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders 17.70%-334.77K-160.05%-547.31K-48.80%-623.28K22.52%-1.43M21.97%-391.31K-3.32%-406.76K60.13%-210.46K0.07%-418.86K-26.71%-1.84M31.29%-501.51K
Diluted earnings per share 0.00%-0.02-295.73%-0.010.00%-0.020.00%-0.0200.00%-0.0274.73%-0.00250.00%-0.020.00%-0.020
Basic earnings per share 0.00%-0.02-295.73%-0.010.00%-0.020.00%-0.0200.00%-0.0274.73%-0.00250.00%-0.020.00%-0.020
Dividend per share
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights

Dividend Kings of Canada Dividend Kings of Canada

Dividend Kings In Canada are companies that have increased their Dividend per share for the most consecutive years, reflecting a strong business model and robust financials, and are likely to outperform the market with less volatility. Dividend Kings In Canada are companies that have increased their Dividend per share for the most consecutive years, reflecting a strong business model and robust financials, and are likely to outperform the market with less volatility.

Unlock Now